Your browser doesn't support javascript.
loading
Cardiovascular risk in myositis patients compared with the general population.
Oreska, Sabina; Storkanova, Hana; Pekacova, Aneta; Kudlicka, Jaroslav; Tuka, Vladimir; Mikes, Ondrej; Krupickova, Zdislava; Satny, Martin; Chytilova, Eva; Kvasnicka, Jan; Spiritovic, Maja; Hermankova, Barbora; Cesak, Petr; Rybar, Marian; Pavelka, Karel; Senolt, Ladislav; Mann, Herman; Vencovsky, Jiri; Vrablik, Michal; Tomcik, Michal.
Afiliação
  • Oreska S; Institute of Rheumatology, Prague, Czech Republic.
  • Storkanova H; Department of Rheumatology, 1st Faculty of Medicine, Charles University, Prague, Czech Republic.
  • Pekacova A; Institute of Rheumatology, Prague, Czech Republic.
  • Kudlicka J; Department of Rheumatology, 1st Faculty of Medicine, Charles University, Prague, Czech Republic.
  • Tuka V; Institute of Rheumatology, Prague, Czech Republic.
  • Mikes O; Department of Rheumatology, 1st Faculty of Medicine, Charles University, Prague, Czech Republic.
  • Krupickova Z; 3rd Department of Internal Medicine, General University Hospital and 1st Faculty of Medicine, Charles University, Prague, Czech Republic.
  • Satny M; 3rd Department of Internal Medicine, General University Hospital and 1st Faculty of Medicine, Charles University, Prague, Czech Republic.
  • Chytilova E; 3rd Department of Internal Medicine, General University Hospital and 1st Faculty of Medicine, Charles University, Prague, Czech Republic.
  • Kvasnicka J; 3rd Department of Internal Medicine, General University Hospital and 1st Faculty of Medicine, Charles University, Prague, Czech Republic.
  • Spiritovic M; 3rd Department of Internal Medicine, General University Hospital and 1st Faculty of Medicine, Charles University, Prague, Czech Republic.
  • Hermankova B; 3rd Department of Internal Medicine, General University Hospital and 1st Faculty of Medicine, Charles University, Prague, Czech Republic.
  • Cesak P; 3rd Department of Internal Medicine, General University Hospital and 1st Faculty of Medicine, Charles University, Prague, Czech Republic.
  • Rybar M; Institute of Rheumatology, Prague, Czech Republic.
  • Pavelka K; Department of Physiotherapy, Faculty of Physical Education and Sport, Charles University, Prague, Czech Republic.
  • Senolt L; Department of Physiotherapy, Faculty of Physical Education and Sport, Charles University, Prague, Czech Republic.
  • Mann H; Department of Human Movement Laboratory, Faculty of Physical Education and Sport, Charles University, Prague, Czech Republic.
  • Vencovsky J; Department of Biomedical Technology, Faculty of Biomedical Engineering, Czech Technical University in Prague, Kladno, Czech Republic.
  • Vrablik M; Institute of Rheumatology, Prague, Czech Republic.
  • Tomcik M; Department of Rheumatology, 1st Faculty of Medicine, Charles University, Prague, Czech Republic.
Rheumatology (Oxford) ; 63(3): 715-724, 2024 Mar 01.
Article em En | MEDLINE | ID: mdl-37279728
ABSTRACT

OBJECTIVES:

We aimed to evaluate cardiovascular (CV) risk in patients with idiopathic inflammatory myopathies (IIM) compared with healthy controls (HC) and to assess its association with disease-specific features.

METHODS:

Ninety IIM patients and 180 age-/sex-matched HC were included. Subjects with a history of CV disease (angina pectoris, myocardial infarction and cerebrovascular/peripheral arterial vascular events) were excluded. All participants were prospectively recruited and underwent examinations of carotid intima-media thickness (CIMT), pulse wave velocity (PWV), ankle-brachial index (ABI), and body composition. The risk of fatal CV events was evaluated by the Systematic COronary Risk Evaluation (SCORE) and its modifications.

RESULTS:

Compared with HC, IIM patients had a significantly higher prevalence of traditional CV risk factors, carotid artery disease (CARD), abnormal ABI and PWV. After propensity score matching (using traditional CV risk factors), the prevalence of CARD and pathological PWV remained significantly higher in IIM than HC. No significant difference in SCORE was observed. The most unfavourable CV risk profile was observed in patients with necrotizing myopathy, especially in statin-induced anti-HMGCR+ patients. The calculated CV risk scores by SCORE, SCORE2 and SCORE multiplied by the coefficient 1.5 (mSCORE) were reclassified according to CIMT and the presence of carotid plaques. SCORE was demonstrated to be most inaccurate in predicting CV risk in IIM. Age, disease activity, lipid profile, body composition parameters and blood pressure were the most significant predictors of CV risk in IIM patients.

CONCLUSION:

Significantly higher prevalence of traditional risk factors and subclinical atherosclerosis was observed in IIM patients compared with HC.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Doenças Cardiovasculares / Doenças das Artérias Carótidas / Miosite Tipo de estudo: Etiology_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Doenças Cardiovasculares / Doenças das Artérias Carótidas / Miosite Tipo de estudo: Etiology_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2024 Tipo de documento: Article